FMR LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,021,902
+31.7%
342,699
+27.7%
0.00%
Q2 2023$5,330,485
-33.3%
268,268
-42.5%
0.00%
Q1 2023$7,990,494
+57.5%
466,462
+80.0%
0.00%
-100.0%
Q4 2022$5,071,761
+22.6%
259,160
+0.0%
0.00%
Q3 2022$4,136,000
+32.6%
259,153
+14.4%
0.00%
Q2 2022$3,118,000
-27.6%
226,599
-16.6%
0.00%
Q1 2022$4,309,000
-54.0%
271,664
-36.7%
0.00%
-100.0%
Q4 2021$9,368,000
-29.8%
429,124
-3.8%
0.00%0.0%
Q3 2021$13,337,000
-46.1%
446,218
-20.2%
0.00%
-50.0%
Q2 2021$24,751,000
-25.0%
558,836
-24.8%
0.00%
-33.3%
Q1 2021$32,986,000
-27.2%
743,436
-10.1%
0.00%
-25.0%
Q4 2020$45,333,000
+144.4%
826,636
+1.9%
0.00%
+100.0%
Q3 2020$18,547,000
-11.5%
811,336
-18.9%
0.00%0.0%
Q2 2020$20,946,000
+30.6%
1,000,779
-12.9%
0.00%0.0%
Q1 2020$16,037,000
-44.7%
1,149,587
-9.7%
0.00%
-33.3%
Q4 2019$28,987,000
+83.0%
1,273,587
-6.3%
0.00%
+50.0%
Q3 2019$15,842,000
-22.3%
1,359,7870.0%0.00%0.0%
Q2 2019$20,397,000
-20.6%
1,359,787
-7.2%
0.00%
-33.3%
Q1 2019$25,697,000
+18.3%
1,465,0990.0%0.00%0.0%
Q4 2018$21,713,000
-17.7%
1,465,099
+36.6%
0.00%0.0%
Q3 2018$26,398,0001,072,1990.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders